Health in Armenia 1,208 indicators covering health for Armenia. IndicatorLatest Year10-yr change Rank Number of deaths attributed to non-communicable diseases, by type of 5,105 2019 down 6.9% 119th Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 down 50.0% 101st Mean hemoglobin level of children aged 6-59 months 119 2019 up 0.8% 59th Estimated number of MDR/RR-TB incident cases 110 2024 down 71.1% 90th Mortality caused by road traffic injury 20 per 100,000 population 2019 up 11.7% 72nd Mortality caused by road traffic injury, female 10.7 per 100,000 female population 2019 up 35.4% 62nd Mortality caused by road traffic injury, male 30.4 per 100,000 male population 2019 up 4.5% 67th Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Ipv vaccine coverage 97 2024 up 185.3% 51st Number of births in thousands 34.93 2025 down 16.4% 52nd Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2024 unchanged 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2024 unchanged 33rd Tb patients living with hiv receiving art 62 2019 up 933.3% 86th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 56.2% 1st Hospital beds 42.4 2023 up 1.0% 33rd Treatment success rate for patients treated for MDR-TB 68.0% 2022 up 54.5% 104th New leprosy case detection rate per 1 000 000 population 0 2024 — 124th Treatment success rate: HIV-positive TB cases 67 2023 up 1.5% 93rd Prevalence of wasting, weight for height 4.4% 2016 down 18.5% 46th Bladder cancer death rate 3.22 2023 down 29.6% 19th Cancer death rates by type who db 3.22 2023 down 29.6% 19th Sex ratio at birth 1.08 2024 down 4.1% 3rd Crude birth rate 11.1 2024 down 22.4% 27th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 97.0% 2025 — 29th International Health Regulations core capacity scores, SPAR version 70 2025 — 49th Prevalence of underweight, weight for age 2.6% 2016 down 38.1% 82nd Leprosy registered prevalence rate per 1 000 000 population 0 2024 — 121st Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 0 2024 — 121st New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th GNI, Atlas method 23.70 billion 2024 up 96.7% 58th GNI per capita, Atlas method 7,810 2024 up 95.2% 51st Children (0-14) living with HIV 100 2024 unchanged 85th Ipv1 number unvaccinated 1,390 2023 down 95.0% 139th Children living with hiv 100 2024 unchanged 85th Contraceptive prevalence, any method 57.1% 2016 up 7.5% 58th Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 26.2% 2024 down 9.3% 38th Liver cancer death rate 8.76 2023 down 11.2% 8th Refugees under the mandate of the UNHCR by country or territory of 144,379 2024 up 718.7% 23rd Number of children newly infected with hiv 100 2024 unchanged 51st Share of children under fifteen years old with hiv 7.97 2024 up 4.0% 81st Number of female leprosy new cases 0 2024 — 102nd Estimated number of malaria deaths 0 2024 — 66th Estimated number of malaria cases 0 2024 — 82nd National smoking ban: NUMBER OF PLACES SMOKE-FREE 7 2022 up 133.3% 73rd Contraceptive prevalence, any modern method 28.0% 2016 up 43.6% 85th Number of prevalent tuberculosis cases 1,700 2014 down 48.5% 119th Estimated malaria incidence 0 2024 — 82nd Estimated malaria mortality rate 0 2024 — 66th Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th Proportion of total government spending on essential services, health 5.1% 2024 down 17.2% 98th Pancreatic cancer death rate 6.38 2023 down 20.6% 47th Brain and nervous system cancer death rate 3.94 2023 down 28.1% 28th Inflation-adjusted prices for most sold brand of cigarettes: Prices 4.95 2022 up 2.3% 114th Taxes as a % of price: total tax 48.5% 2022 up 94.0% 112th Taxes as a % of price: value added tax 16.7% 2022 up 233.4% 26th Taxes as a % of price: ad valorem excise 0.0% 2022 — 106th ← Previous Page 16 of 21 Next →